All Journals All Articles | Search Log In
Articles Special Topics Volumes Webinars Videos
Home Journals CDR
Articles Special Topics Volumes Webinars Interviews

Cancer Drug Resistance

Open Access

Editor-in-Chief : Godefridus J. Peters

Indexing : ESCI, PMC, Scopus, CAS, CNKI, Dimensions, Lens, Embase, ASCI

Journal Flyer
7.6 Impact Factor
10.3 CiteScore
9 days Time to First Decision
Cancer Drug Resistance
View Articles

About the journal

A dedicated home for research on cancer drug resistance.

Cancer Drug Resistance is an international Open Access journal dedicated to understanding and overcoming treatment resistance in cancer. We publish basic, translational, and clinical research on the mechanisms, evolution, biomarkers, and therapeutic strategies underlying or reversing resistance.

Key areas include: targeted therapies · immunotherapy · antibody–drug conjugates · radioligand therapy · cellular therapies · liquid biopsy · cancer evolution · emerging resistance mechanisms and therapeutic approaches.

More

Search Cancer Drug Resistance

Featured Articles

Articles

Most Recent | Most Viewed | Most Downloaded

Most Cited Papers in Last Two Years

NFE2L2 and ferroptosis resistance in cancer therapy

Daolin TangDaolin Tang, Rui Kang
24 Oct 2024

Call For Papers

Call for papers

Topics Collection

Topic: Overcoming Drug Resistance in Solid Tumors: Nanotechnology, Precision Medicine, and Multimodal Therapies Topic: Overcoming Drug Resistance in Solid Tumors: Nanotechnology, Precision Medicine, and Multimodal Therapies Submission deadline: 26 Jun 2026Topic: Advancements in Precision Medicine for Overcoming Cancer Drug Resistance Topic: Advancements in Precision Medicine for Overcoming Cancer Drug Resistance Submission deadline: 30 Dec 2025Topic: Genomic and Genetic Alterations Associated with Cancer Drug Resistance Topic: Genomic and Genetic Alterations Associated with Cancer Drug Resistance Submission deadline: 20 Nov 2025

Academic Talks

Breaking Resistance, Shaping the Future | Research Voices (Episode 7) - Prof. Mary V. Relling, St. Jude Children's Research Hospital
Breaking Resistance, Shaping the Future | Research Voices (Episode 6) - Prof. Paul Hofman, IHU RespirERA
Breaking Resistance, Shaping the Future | Research Voices (Episode 5) - Prof. Naoto T. Ueno, University of Hawai'i Cancer Center
Editorial Board
Godefridus J. Peters Godefridus J. PetersWafik S. El-Deiry Wafik S. El-DeiryElisa Giovannetti Elisa GiovannettiPaola Perego Paola PeregoChiara Riganti Chiara RigantiBaiyong Shen Baiyong Shen
Partners
Related Journals

Extracellular Vesicles and Circulating Nucleic Acids

Editor-in-Chief: Yoke Peng Loh

Journal of Cancer Metastasis and Treatment

Breaking Resistance, Shaping the Future | Research Voices (Episode 6) - Prof. Paul Hofman, IHU RespirERA
Call for Applications: <em>Cancer Drug Resistance</em> Early-Career Editorial Board
Breaking Resistance, Shaping the Future | Research Voices (Episode 5) - Prof. Naoto T. Ueno, University of Hawaiʻi Cancer Center
Breaking Resistance, Shaping the Future | Research Voices (Episode 4)
Breaking Resistance, Shaping the Future | Editorial Board Voices (Episode 3)

Prof. Paul Hofman Reflects on Liquid Biopsy, Multi-Omics Integration, and Ultra-Stratified Personalized Medicine in Thoracic Oncology

7.6 Impact Factor
10.3 CiteScore
Featured Articles

Mitochondria in colorectal cancer stem cells - a target in drug resistance
BY Mateus de Almeida Rainho, ... Alessandra Alves Thole

Mechanisms involved in cancer stem cell resistance in head and neck squamous cell carcinoma
BY Juliana Mota Siqueira, ... Maria Fernanda Setúbal Destro Rodrigues

P-glycoprotein (ABCB1) - weak dipolar interactions provide the key to understanding allocrite recognition, binding, and transport
BY Anna Seelig, Xiaochun Li-Blatter

Heterotypic signaling of cancer-associated fibroblasts in shaping the cancer cell drug resistance
BY Ramesh Butti, ... Gopinath Prakasam

Targeting regulated cell death pathways in acute myeloid leukemia
BY Sylvain Garciaz, ... Norbert Vey
Articles
Most Cited Papers in Last Two Years
Call For Papers
Topics Collection
Topic: Overcoming Drug Resistance in Solid Tumors: Nanotechnology, Precision Medicine, and Multimodal Therapies
Topic: Overcoming Drug Resistance in Solid Tumors: Nanotechnology, Precision Medicine, and Multimodal Therapies Submission deadline: 26 Jun 2026
Topic: Advancements in Precision Medicine for Overcoming Cancer Drug Resistance
Topic: Advancements in Precision Medicine for Overcoming Cancer Drug Resistance Submission deadline: 30 Dec 2025
Topic: Genomic and Genetic Alterations Associated with Cancer Drug Resistance
Topic: Genomic and Genetic Alterations Associated with Cancer Drug Resistance Submission deadline: 20 Nov 2025
Academic Talks
Breaking Resistance, Shaping the Future | Research Voices (Episode 7) - Prof. Mary V. Relling, St. Jude Children's Research Hospital

Breaking Resistance, Shaping the Future | Research Voices (Episode 7) - Prof. Mary V. Relling, St. Jude Children's Research Hospital

Editorial Board
Godefridus J. Peters Godefridus J. PetersWafik S. El-Deiry Wafik S. El-DeiryElisa Giovannetti Elisa GiovannettiPaola Perego Paola PeregoChiara Riganti Chiara RigantiBaiyong Shen Baiyong Shen
1 / 9
Partners
PartnerPartnerPartnerPartnerPartnerPartner
Related Journals
Extracellular Vesicles and Circulating Nucleic Acids Extracellular Vesicles and Circulating Nucleic Acids Editor-in-Chief: Yoke Peng LohJournal of Cancer Metastasis and Treatment Journal of Cancer Metastasis and Treatment
Cancer Drug Resistance
ISSN 2578-532X (Online)
Navigation
Follow Us
Navigation

Committee on Publication Ethics

https://members.publicationethics.org/members/cancer-drug-resistance

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Committee on Publication Ethics

https://members.publicationethics.org/members/cancer-drug-resistance

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/
Contact Us
Follow OAE
Twitter
Facebook
LinkedIn
YouTube
BiLiBiLi
WeChat
Rss
© 2016-2026 OAE Publishing Inc., except certain content provided by third parties